Lack of association of NQO1 and GSTP1 polymorphisms with multiple myeloma risk

Leukemia Research

Volumn 32, Issue 6, 2008, Pages 988-990

  Maggini, Valentina ^a   Buda, Gabriele ^a   Galimberti, Sara ^a   Martino, Alessandro ^a   Orciuolo, Enrico ^a   Morabito, Fortunato ^b   Bono, Roberto ^c   Barale, Roberto ^a   Petrini, Mario ^a   Rossi, Anna Maria ^a  

^a UNIVERSITY OF PISA   (Italy)

^b Annunziata Hospital   (Italy)

^c UNIVERSITY OF TURIN   (Italy)

Author keywords

Genetic susceptibility; Glutathione S transferase; Multiple myeloma; NAD(P)H:quinone oxidoreductase

Indexed keywords

GLUTATHIONE TRANSFERASE P1; NADPH QUINONE OXIDOREDUCTASE; OXIDOREDUCTASE; UNCLASSIFIED DRUG;

ADULT; AGED; ALLELE; ARTICLE; CANCER RISK; CONTROLLED STUDY; DISEASE ASSOCIATION; DISEASE MARKER; DNA POLYMORPHISM; FEMALE; HUMAN; MAJOR CLINICAL STUDY; MALE; MULTIPLE MYELOMA; OUTCOME ASSESSMENT; PATHOGENESIS; PRIORITY JOURNAL; PROGNOSIS; SINGLE NUCLEOTIDE POLYMORPHISM;

ALLELES; CASE-CONTROL STUDIES; FEMALE; GENOTYPE; GLUTATHIONE S-TRANSFERASE PI; HUMANS; ITALY; MALE; MIDDLE AGED; MULTIPLE MYELOMA; NAD(P)H DEHYDROGENASE (QUINONE); POLYMORPHISM, GENETIC; RISK FACTORS;

EID: 40749141514     PISSN: 01452126     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.leukres.2007.10.008     Document Type: Article

References (11)

1. Infante P.F. Benzene exposure and multiple myeloma: a detailed meta-analysis of benzene cohort studies. Ann N Y Acad Sci 1076 (2006) 90-109
2. Snyder R., and Hedli C.C. An overview of benzene metabolism. Environ Health Perspect 104 Suppl. 6 (1996) 1165-1171
3. Rossi A.M., Guarnieri C., Rovesti S., Gobba F., Ghittori S., Vivoli G., et al. Genetic polymorphisms influence variability in benzene metabolism in humans. Pharmacogenetics 9 4 (1999) 445-451
4. Wan J., Shi J., Hui L., Wu D., Jin X., Zhao N., et al. Association of genetic polymorphisms in CYP2E1, MPO, NQO1, GSTM1, and GSTT1 genes with benzene poisoning. Environ Health Perspect 110 12 (2002) 1213-1218
5. Chen Y., Li G., Yin S., Xu J., Ji Z., Xiu X., et al. Genetic polymorphisms involved in toxicant-metabolizing enzymes and the risk of chronic benzene poisoning in Chinese occupationally exposed populations. Xenobiotica 37 1 (2007) 103-112
6. Lincz L.F., Scorgie F.E., Robertson R., and Enno A. Genetic variations in benzene metabolism and susceptibility to multiple myeloma. Leuk Res 31 6 (2007) 759-763
7. Yuille M., Condie A., Hudson C., et al. Relationship between glutathione S-transferase M1, T1, and P1 polymorphisms and chronic lymphocytic leukemia. Blood 99 11 (2002) 4216-4218
8. Soucek P. Role of genetic factors in development and progression of non-Hodgkin's lymphomas. Cent Eur J Public Health 9 2 (2001) 74-78
9. Maggini V., Buda G., Galimberti S., et al. Response to chemotherapy and tandem autologous transplantation of multiple myeloma patients and GSTP1 and TYMS polymorphisms. Leuk Res 32 (2008) 49-53
10. Dasgupta R.K., Adamson P.J., Davies F.E., Rollinson S., Roddam P.L., Ashcroft A.J., et al. Polymorphic variation in GSTP1 modulates outcome following therapy for multiple myeloma. Blood 102 7 (2003) 2345-2350
11. Buda G., Maggini V., Galimberti S., Barale R., Rossi A.M., and Petrini M. NQO1(*)2 polymorphism and response to treatment in patients with multiple myeloma. Leuk Res 31 8 (2007) 1029-1030